WENTWORTH TIMOTHY C 4
4 · QUEST DIAGNOSTICS INC · Filed Apr 2, 2026
Research Summary
AI-generated summary of this filing
Quest Diagnostics Director Timothy Wentworth Receives 198-Unit Award
What Happened Timothy C. Wentworth, a director of Quest Diagnostics Inc. (DGX), was granted 198 phantom stock units on April 1, 2026. The Form 4 reports these as a derivative award (code A) acquired at $0.00 per unit — a deferred compensation award rather than a cash purchase or open-market sale.
Key Details
- Transaction date: 2026-04-01; Filing date: 2026-04-02 (filed next day; not marked late).
- Award: 198 phantom stock units; reported acquisition price $0.00 per unit.
- Shares/units owned after transaction: not specified in this filing.
- Footnote: These are phantom stock units from the Quest Diagnostics Deferred Compensation Plan for Directors and become payable in cash upon the director’s termination of service.
- Transaction type: Derivative award (not a market buy or sale).
Context Phantom stock units are a form of deferred cash compensation tied to company stock value; they do not represent immediate ownership of common shares and are payable in cash when the director leaves service. Such grants are typically routine compensation actions for board members and should not be interpreted as an immediate bullish or bearish trade.
Insider Transaction Report
- Award
Phantom Stock Units
[F1]2026-04-01+198→ 198 totalExercise: $0.00→ Common Stock (198 underlying)
Footnotes (1)
- [F1]Phantom stock units resulting from elective deferrals of a director's cash compensation pursuant to the Quest Diagnostics Incorporated Amended and Restated Deferred Compensation Plan for Directors and become payable in cash upon the reporting person's termination of service as a director.